Memphis Pharmaceuticals (MPCI.CA) - Board of Directors' Decisions
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decisions held on 14/03/2022
BoD Decisions (118 KB)
Release from the Company (48 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The Board of Directors' decisions held on 14/03/2022
BoD Decisions (118 KB)
Release from the Company (48 KB)
Comments